SLC25A20 and cardiomyopathy: The critical role of the CAC in energy metabolism is underscored by findings that mutations in its gene (SLC25A20) can cause a severe, early-onset disease (secondary carnitine deficiency) [4,5,6,7], characterised by profound cardiomyopathy, respiratory distress, and liver dysfunction [8,9].